Superior Mesenteric Artery Syndrome Managed with Laparoscopic Duodenojejunostomy.

IF 1.3 Q3 SURGERY
Minimally Invasive Surgery Pub Date : 2022-08-03 eCollection Date: 2022-01-01 DOI:10.1155/2022/4607440
Ahmed Sabry, Ramy Shaalan, Carl Kahlin, Ahmed Elhoofy
{"title":"Superior Mesenteric Artery Syndrome Managed with Laparoscopic Duodenojejunostomy.","authors":"Ahmed Sabry,&nbsp;Ramy Shaalan,&nbsp;Carl Kahlin,&nbsp;Ahmed Elhoofy","doi":"10.1155/2022/4607440","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Superior mesenteric artery (SMA) syndrome is a rare disorder that may be managed surgically if conservative management fails. Different surgical techniques have been described, division of the ligament of Treitz, gastrojejunostomy, and duodenojejunostomy. The aim of this case series is to show that laparoscopic duodenojejunostomy is a safe and technically feasible management for superior mesenteric artery syndrome.</p><p><strong>Methods: </strong>In this case series, we retrospectively identified all patients who underwent laparoscopic duodenojejunostomy for SMA syndrome in our tertiary university center between December 2016 and July 2019. Data collected included demographics, presenting symptoms, comorbidities, pre and postoperative body mass index (BMI), operative approach, operative blood loss, operative duration, clinical and radiological results, in hospital/30-day complications, mortality, and postoperative follow-up outcomes.</p><p><strong>Results: </strong>We identified eleven patients, 10 females and 1 male, with a median age 23 years (range 17-43 years). All patients had refractory symptoms after a minimum of two months of conservative management and subsequently underwent laparoscopic duodenojejunostomy. There were no intraoperative complications and no in-hospital or 30-day postoperative mortality or complications were identified. Follow-up data showed complete resolution in 73% of patients (<i>n</i> = 8) and only one patient with no improvement postoperatively. Results also showed a median BMI increase of 2 kg/m<sup>2</sup> (range 1-9 kg/m<sup>2</sup>) at a median follow-up of 16 months (range 4-48 months).</p><p><strong>Conclusion: </strong>Laparoscopic duodenojejunostomy is a safe treatment option for SMA syndrome and should be considered when patients do not respond to conservative management.</p>","PeriodicalId":45110,"journal":{"name":"Minimally Invasive Surgery","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2022-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365593/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minimally Invasive Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/4607440","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Superior mesenteric artery (SMA) syndrome is a rare disorder that may be managed surgically if conservative management fails. Different surgical techniques have been described, division of the ligament of Treitz, gastrojejunostomy, and duodenojejunostomy. The aim of this case series is to show that laparoscopic duodenojejunostomy is a safe and technically feasible management for superior mesenteric artery syndrome.

Methods: In this case series, we retrospectively identified all patients who underwent laparoscopic duodenojejunostomy for SMA syndrome in our tertiary university center between December 2016 and July 2019. Data collected included demographics, presenting symptoms, comorbidities, pre and postoperative body mass index (BMI), operative approach, operative blood loss, operative duration, clinical and radiological results, in hospital/30-day complications, mortality, and postoperative follow-up outcomes.

Results: We identified eleven patients, 10 females and 1 male, with a median age 23 years (range 17-43 years). All patients had refractory symptoms after a minimum of two months of conservative management and subsequently underwent laparoscopic duodenojejunostomy. There were no intraoperative complications and no in-hospital or 30-day postoperative mortality or complications were identified. Follow-up data showed complete resolution in 73% of patients (n = 8) and only one patient with no improvement postoperatively. Results also showed a median BMI increase of 2 kg/m2 (range 1-9 kg/m2) at a median follow-up of 16 months (range 4-48 months).

Conclusion: Laparoscopic duodenojejunostomy is a safe treatment option for SMA syndrome and should be considered when patients do not respond to conservative management.

Abstract Image

Abstract Image

Abstract Image

腹腔镜十二指肠空肠吻合术治疗肠系膜上动脉综合征。
背景:肠系膜上动脉(SMA)综合征是一种罕见的疾病,如果保守治疗失败,可以手术治疗。不同的手术技术已被描述,韧带的划分,胃空肠吻合术,和十二指肠空肠吻合术。本病例系列的目的是表明腹腔镜十二指肠空肠吻合术是一种安全且技术上可行的治疗肠系膜上动脉综合征的方法。方法:在本病例系列中,我们回顾性分析了2016年12月至2019年7月在我们的第三大学中心接受腹腔镜十二指肠空肠造口术治疗SMA综合征的所有患者。收集的数据包括人口统计学、症状、合并症、术前和术后体重指数(BMI)、手术入路、手术出血量、手术持续时间、临床和放射学结果、住院/30天并发症、死亡率和术后随访结果。结果:我们确定了11例患者,10例女性,1例男性,中位年龄23岁(范围17-43岁)。所有患者在保守治疗至少两个月后出现难治性症状,随后行腹腔镜十二指肠空肠吻合术。无术中并发症,无院内或术后30天死亡率或并发症。随访数据显示73%的患者(n = 8)完全缓解,只有1例患者术后无改善。结果还显示,在中位随访16个月(范围4-48个月)时,BMI中位数增加了2 kg/m2(范围1-9 kg/m2)。结论:腹腔镜十二指肠空肠吻合术是SMA综合征的一种安全的治疗选择,当患者对保守治疗无反应时应予以考虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
0.00%
发文量
8
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信